How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

497 results for

Superficial Thrombophlebitis

Latest & greatest

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. What Is Vascular Behçet’s Disease? (Full text)

are follows; saccular aneurysms without atherosclerosis developed in younger than 50-year-old patients, superior vena cava syndrome or deep vein thrombosis in bilateral legs without apparent causes, and multiple superficial thrombophlebitis, etc. It is very difficult to make a diagnosis of BD in the patients whose onset of the disease is a vascular lesion, because vascular BD combines few ocular lesions. In such case, it is very important to find out not only oral and genital ulceration, but also past

2018 Annals of vascular diseases PubMed abstract

122. Study of Peripherally Inserted Venous Catheters in Cystic Fibrosis Patients

with higher scores representing worse outcome. One point is added to a baseline score of 0 for each of the following: indwelling venous material, localized pain, unilateral pitting edema. One point is subtracted for another diagnosis being at least as plausible as venous thrombosis. Secondary Outcome Measures : Development of catheter related local phlebitis or superficial thrombophlebitis [ Time Frame: While the catheter is in place, an average of two weeks ] Phlebitis as defined by a Visual Infusion (...) the IV site; 5- All of the following: Pain, erythema, palpable venous cord and fever >38 degrees centigrade. Thrombophlebitis is defined by phlebitis associated with superficial thrombosis as detected by ultrasound or venogram. Central line associated blood stream infection (CLABSI) [ Time Frame: While the catheter is in place, an average of two weeks ] The study definition for CLABSI follows the Centers for Disease Control guidelines Number of participants with catheter associated deep venous

2018 Clinical Trials

123. Evaluation of Cirvoâ„¢ Mobile Compression Device for Treatment of Venous Leg Ulcers

documented by venous reflex ultrasound showing mild, moderate, or severe reflux in the superficial or deep venous system Exclusion Criteria: Acute DVT within the 3 months prior to enrollment Ulcer present for <2 weeks Ulcers extending with exposed fascia, tendon, or bone within the wound margins Lateral malleolus ulcers Ulcers with perforator incompetence deep to the ulceration (within 5 cm of the wound border) Active infection (systemic or in the affected limb) Lower extremity gangrene Diabetes mellitus (...) (Type I or II) requiring medication History of pulmonary vascular disease (PVD) History of pulmonary edema History of decompensated congestive heart failure (CHF) Open surgery or major trauma to the legs within the last six months History of lower limb malignancy, primary or secondary Acute symptomatic lower extremity thrombophlebitis Pregnant or breastfeeding Calf geometry on which Cirvo(TM) device does not appropriately fit Known sensitivity to any of the materials used in the Cirvo(TM) device

2018 Clinical Trials

124. Effects of Functional Electrical Stimulation in Patients Undergoing Coronary Artery Bypass Grafting Surgery

the survey Chronic respiratory diseases Hemodynamic instability Orthopedic and neurological diseases that may preclude the achievement of the cardiopulmonary test and Cardiac Rehabilitation exercises Psychological and/or cognitive impairment that restrict them to respond to questionnaires Changes of skin sensitivity,skin lesion and allergic skin problems Severe lymphedema Uncontrolled diabetes mellitus Acute superficial venous thrombophlebitis Systemic arterial hypertension Contacts and Locations Go

2018 Clinical Trials

125. Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and functional hypothalamic amenorrhea: a systematic review of the literature and a meta-analysis. (Full text)

randomized and 32 observational) encompassing 1,002 women with HA.None.Primary outcomes: ovulation rate (OvR), pregnancy per ovulatory cycle rate (POR), and live birth per ovulatory cycle rate (LBOR).multiple gestation (MG), ovarian hyperstimulation syndrome (OHSS), and superficial thrombophlebitis (ST) rates. The summary measures were expressed as proportions and 95% confidence intervals (CI).Pulsatile GnRH treatment appears to achieve high OvRs. A trend toward high PORs and LBORs among women with HA

2018 Fertility and Sterility PubMed abstract

127. Management of Venous Leg Ulcers: Clinical Practice Guidelines of the Society for Vascular Surgery and the American Venous Forum (Full text)

MANAGEMENT Guideline 6.1: Superficial Venous Reflux and Active Venous Leg Ulcer—Ulcer Healing In a patient with a venous leg ulcer (C6) and incompetent superficial veins that have axial reflux directed to the bed of the ulcer, we suggest ablation of the incompetent veins in addition to standard compressive therapy to improve ulcer healing. [GRADE - 2; LEVEL OF EVIDENCE - C] Guideline 6.2: Superficial Venous Reflux and Active Venous Leg Ulcer—Prevent Recurrence In a patient with a venous leg ulcer (C6 (...) ) and incompetent superficial veins that have axial reflux directed to the bed of the ulcer, we recommend ablation of the incompetent veins in addition to standard compressive therapy to prevent recurrence. [GRADE - 1; LEVEL OF EVIDENCE - B] Guideline 6.3: Superficial Venous Reflux and Healed Venous Leg Ulcer In a patient with a healed venous leg ulcer (C5) and incompetent superficial veins that have axial reflux directed to the bed of the ulcer, we recommend ablation of the incompetent veins in addition

2014 American Venous Forum PubMed abstract

128. The challenges of developing healthcare quality measures based on ICD-10-CM Codes

version of ICD-10-CM — 91,738 versus 17,553 in ICD-9-CM — required a painstaking, time-consuming process involving multiple iterations of the classification scheme over several months. Previous ICD-9-CM-based schemes did not naturally translate to ICD-10-CM. In some cases, ICD-9-CM diagnosis codes were more detailed than ICD-10-CM. For example, non-infected superficial wounds such as insect bites and abrasions were differentiated from their infected counterparts in ICD-9-CM, but not ICD-10-CM (...) . In other cases, ICD-10-CM codes were more detailed than the corresponding ICD-9-CM codes. Few ICD-10-CM codes have been validated against medical chart review. Thus, our team often lacked information on the clinical scenario that a clinician was trying to convey by using a given diagnosis code. As an example, a clinician using a diagnosis code of thrombophlebitis might be treating a patient with an uncomplicated case who would not require antibiotics, or a patient with infected thrombophlebitis who

2019 The BMJ Blog

129. Contraception in women at cardiovascular risk

, with or without aura. ´ Tobacco consumption. Generalities How to identify a woman at cardiovascular risk? ´ Deep vein thrombosis (DVT)/pulmonary embolism (PE). ´ Superficial thrombophlebitis. ´ Hereditary thrombosis risk factors (factor V Leiden mutation [Factor V Leiden], 20210G>A mutation of the prothrombin gene [FII 20210A], antithrombin [AT], protein C [PC], protein S [PS] deficiency). ´ Stroke. ´ Ischaemic heart disease. ´ Cardiac valvulopathies. ´ Headaches, migraines. ´ Systemic lupus erythematosus (...) Oestrogen-progestogen contraceptive methods (COC, patch, CCVR) Minor surgery without immobilisation All methods Superficial thrombophlebitis Progestogen-only methods (PMP, progestogen-only injectable, implant), LNG-IUD, Cu-IUD, barrier, natural methods Oestrogen-progestogen contraceptive methods* (COC, patch, CCVR) History of STP or spontaneous STP in healthy veins Progestogen-only methods (PMP, progestogen-only injectable, implant), LNG-IUD, Cu-IUD, barrier, natural methods Oestrogen-progestogen

2013 HAS Guidelines

131. Varicose veins. Natural history, assessment and management.

be a good reason to refer them for a specialist opinion. there is extensive debate on the treatment of patients with uncomplicated varicose veins in the public health system, with much to be said for a very conservative approach in this category of patients. some funding agencies will not support payment for this group. many public guidelines, including Australian guidelines, suggest that only • skin pigmentation • eczema. less common symptoms include ulceration, superficial thrombophlebitis (...) , disadvantages and long term outcomes. Objective To describe the natural history, assessment and management of varicose veins. Discussion Surgical or other intervention is only necessary in a small percentage of patients, and is seldom urgent, perhaps only in the setting of progressive thrombophlebitis. Duplex ultrasound has become an essential modality for diagnosis, treatment and follow up. All the current modalities of endoluminal and open surgical treatment have similar short term outcomes and risks

2013 Clinical Practice Guidelines Portal

132. Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis

), and to recognize groups of patients in which treatment with heparin is most efficient, as well as to determine factors that influence the efficacy of SVT treatment with heparin. Condition or disease Intervention/treatment Phase Superficial Thrombophlebitis Drug: Dalteparin Phase 4 Detailed Description: Until recently thrombophlebitis was regarded as a benign and self-limiting disease. Recent studies have shown that various complications, especially vein thrombosis and pulmonary thromboembolism, often accompany (...) SVT. An observational study (Prospective Observational Superficial Thrombophlebitis - POST) showed that three months after onset of the disease thromboembolic events occurred in 10% of patients: pulmonary embolism in 0.4%, disease progression in 3.1% and disease recurrence in 1.9% of patients. Therefore, SVT is now frequently regarded as a part of the thromboembolic syndrome. On the basis of the evidence referred to above anticoagulants, especially heparin, are used more and more often

2010 Clinical Trials

133. Investigation and Management of Antiphospholipid Syndrome

). Venous thrombosis in APS is most commonly lower limb deep vein thrombosis (DVT) and/or pulmonary embolism (PE) but any part of the venous system may be involved, including superficial, portal, renal, mesenteric and intracranial veins. The most frequent site of arterial thrombosis in APS is in the cerebral vasculature resulting in transient cerebral ischaemia/stroke. Myocardial infarction is less common, although subclinical myocardial ischaemia may be under‐recognized (Sacre et al , ). Despite

2012 British Committee for Standards in Haematology

134. Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy

mIU/mL at Screening. Have ≤ 5% superficial cells on vaginal smear cytology. Have a vaginal pH > 5.0. At least one of the following patient self-assessed moderate to severe symptoms of VVA from the following list that is identified by the patient as being the most bothersome to her: Vaginal Dryness Vaginal and/or Vulvar Irritation/Itching Dysuria Vaginal Pain associated with sexual activity Vaginal Bleeding associated with sexual activity (presence or absence) Provided that patient is currently (...) thrombophlebitis or thromboembolic disorder. Any prescription treatment for vaginal dryness/irritation within 14 days before Screening or any over-the-counter or natural remedies within 7 days before Screening. Any prescription treatment for bacterial or yeast infections within 30 days before Screening. Fasting triglyceride levels > 350 mg/dL. History of radiation therapy or recent (within previous 6 weeks) surgical therapy to the vaginal or cervical areas. Any known or suspected allergies

2017 Clinical Trials

135. A Study Evaluating ClariVein With a Sclerosing Agent for the Treatment of Venous Insufficiency

demonstrated by a history of peripheral arterial disease (PAD) that would preclude the wearing of compression stockings Absence of a palpable pulse at posterior tibial or dorsalis pedis and an Ankle-Brachial Index (ABI) <0.6 Multi-segmental axial deep venous reflux in at least two contiguous venous segments (e.g., femoral and popliteal) in the ipsilateral extremity Previous surgical or endovenous procedure in the treatment section of the target vein Previous superficial thrombophlebitis of the target (...) Go to Layout table for study information Study Type : Interventional (Clinical Trial) Estimated Enrollment : 50 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double (Participant, Investigator) Primary Purpose: Treatment Official Title: A Prospective, Randomized, Controlled, Multi-Center, Double Blind Study of ClariVein RES for Treatment of Venous Insufficiency Associated With Incompetent Saphenous Veins Due to Superficial Venous Reflux Actual Study Start

2017 Clinical Trials

136. Lower Limb Blood Flow Geko vs Foot Pump

electrostimulation (NMES) device A mobile peroneal nerve stimulator Other Name: Geko T-1 Device: Intermittent pneumatic compression (IPC) device A foot pump or foot compression device Other Name: Vadoplex Outcome Measures Go to Primary Outcome Measures : Venous flow at baseline [ Time Frame: "t0" - 30 minutes to include the ultrasound assessment, performed between days 1 and 4 post operatively ] Measured within the superficial femoral vein using ultrasound Venous flow after application of device 1 [ Time Frame (...) : "t1" - 90 minutes to include the ultrasound assessment ] Measured within the superficial femoral vein using ultrasound Venous flow after application of device 2 [ Time Frame: "t2" - 150 minutes to include the ultrasound assessment ] Measured within the superficial femoral vein using ultrasound Secondary Outcome Measures : Patient satisfaction with device 1 [ Time Frame: Immediately after completion of the ultrasound assessment for device 1, at "t1" - 90 minutes ] verbal rating score: 1 extremely

2017 Clinical Trials

137. Evaluation of Medical Device

of the need to maintain an intravenous or urinary catheter. Adjusting the prescription in terms of duration or withdrawal of the device in order to limit their complications (lymphangitis, superficial thrombophlebitis, bacteremia related to health care, urinary tract infection). Hypothesis: Limit the length of stay and reduce the cost of hospitalization. Condition or disease Acute Infectious Diseases Study Design Go to Layout table for study information Study Type : Observational Estimated Enrollment

2017 Clinical Trials

138. Penile Mondor's disease in a patient treated with radical chemoradiation for anal cancer (Full text)

Penile Mondor's disease in a patient treated with radical chemoradiation for anal cancer Penile Mondor's disease is a rare condition characterized by sclerosing thrombophlebitis of the superficial dorsal penile vein. Usually its causes are benign, but it is also evident in cancer patients. We report the case of a 62-year-old man with a cT4 anal cancer (infiltration of corpora spongiosa and penile bulb), associated with extensive loco-regional lymphadenopathy, who developed painful lumps

2017 Oxford Medical Case Reports PubMed abstract

139. Early experience of transilluminated cryosurgery for varicose vein with saphenofemoral reflux: review of 84 patients (131 limbs) (Full text)

for varicose veins.One hundred thirty-one limbs in 84 patients (37 male, 47 female; mean age, 53.3 years) with varicose veins were treated with cryosurgery over a 2-year period. The patients were followed for postoperative complication with surveillance of recurrence. The analyzed variables included age, sex, symptom, operative time (from skin incision to the application of elastic bandages on the legs for compression purposes), and postoperative complications including bruising, hematoma, superficial (...) thrombophlebitis, cellulitis, seroma, cutaneous nerve damage, and wound complication.The mean operative time was 64.7 minutes for both limbs and 44 minutes for single limbs. The median number of incisions was 2. For stripping of GSV, one incision at the groin was necessary. Postoperative complications included an episode of hematoma in 3 limbs (2.3%), cutaneous nerve damage in 3 limbs (2.3%), cellulitis in 2 patients (1.5%), and seroma in 1 limb (0.8%). No wound infection, thrombophlebitis or deep venous

2017 Annals of surgical treatment and research PubMed abstract

140. Perforator Vein Injection for Symptomatic Venous Disease

significant great or small saphenous reflux Disseminated malignancy or other terminal condition where subject is expected to live less than 6 months. Significant arterial disease (ABI < .8) Buergers disease Acute superficial thrombophlebitis Phlebitis migrans Acute cellulitis Clinical evidence of active local or systemic infection Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using (...) due to venous disease. The investigators believe that venous hypertension is the underlying cause of venous ulceration. Three mechanisms leading to venous hypertension are well-recognized: superficial vein (great, accessory and small saphenous) incompetence; deep vein (common and superficial femoral, popliteal and tibial) reflux or obstruction; perforating vein incompetence. Patients with venous stasis and ulceration may have any or all of these conditions. Currently there are excellent treatments

2017 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>